The corporate social responsibility of the pharmaceutical industry: idealism without illusion and realism without resignation
- PMID: 16358443
- DOI: 10.5840/beq200515440
The corporate social responsibility of the pharmaceutical industry: idealism without illusion and realism without resignation
Abstract
In recent years society has come to expect more from the "socially-responsible" company and the global HIV/AIDS pandemic in particular has resulted in some critics saying that the "Big Pharma" companies have not been living up to their social responsibilities. Corporate social responsibility can be understood as the socio-economic product of the organizational division of labor in complex modern society. Global poverty and poor health conditions are in the main the responsibilities of the world's national governments and international governmental organizations, which possess society's mandate and appropriate organizational capabilities. Private enterprises have neither the societal mandate nor the organizational capabilities to feed the poor or provide health care to the sick in their home countries or in the developing world. Nevertheless, private enterprises do have responsibilities to society that can be categorized as what they must do, what they ought do, and what they can do.
Similar articles
-
Some questions about the moral responsibilities of drug companies in developing countries.Dev World Bioeth. 2001 May;1(1):33-7. doi: 10.1111/1471-8847.00005. Dev World Bioeth. 2001. PMID: 12870506 No abstract available.
-
Developing drugs for the developing world: an economic, legal, moral, and political dilemma.Dev World Bioeth. 2001 May;1(1):11-32. doi: 10.1111/1471-8847.00004. Dev World Bioeth. 2001. PMID: 12870505
-
Introduction: ethical responsibilities regarding drugs, patents, and health.Bus Ethics Q. 2005 Oct;15(4):543-7. doi: 10.5840/beq200515442. Bus Ethics Q. 2005. PMID: 16358441 No abstract available.
-
Corporate social responsibility in global health: an exploratory study of multinational pharmaceutical firms.Global Health. 2015 Apr 9;11:15. doi: 10.1186/s12992-015-0100-5. Global Health. 2015. PMID: 25886175 Free PMC article. Review.
-
Community health outreach program of the Chad-Cameroon petroleum development and pipeline project.Clin Occup Environ Med. 2004 Feb;4(1):9-26. doi: 10.1016/j.coem.2003.09.004. Clin Occup Environ Med. 2004. PMID: 15043361 Review.
Cited by
-
Journey from an Enabler to a Strategic Leader: Integration of the Medical Affairs Function in ESG Initiatives and Values.Pharmaceut Med. 2023 Nov;37(6):405-416. doi: 10.1007/s40290-023-00485-9. Epub 2023 Jul 18. Pharmaceut Med. 2023. PMID: 37464231 Free PMC article.
-
Corporate social responsibility of pharmaceutical industry in Korea.Front Pharmacol. 2022 Aug 23;13:950669. doi: 10.3389/fphar.2022.950669. eCollection 2022. Front Pharmacol. 2022. PMID: 36081939 Free PMC article.
-
Carbovigilance: curtailing the global pharmaceutical carbon footprint.Future Healthc J. 2021 Nov;8(3):e683-e685. doi: 10.7861/fhj.2021-0071. Future Healthc J. 2021. PMID: 34888465 Free PMC article.
-
Public health and corporate social responsibility: exploratory study on pharmaceutical companies in an emerging market.Global Health. 2020 Dec 10;16(1):117. doi: 10.1186/s12992-020-00646-4. Global Health. 2020. PMID: 33302949 Free PMC article.
-
Disease burden metrics and the innovations of leading pharmaceutical companies: a global and regional comparative study.Global Health. 2020 Sep 10;16(1):80. doi: 10.1186/s12992-020-00610-2. Global Health. 2020. PMID: 32912258 Free PMC article.